Amyloid β-peptide (Aβ) is a major component of plaques in Alzheimer's disease, and formation of senile plaques has been suggested to originate from regions of neuronal membrane rich in gangliosides. We analyzed the mode of interaction of Aβ with lipid bilayers by multinuclear NMR using 31 P nuclei. We found that Aβ (1-40) strongly perturbed the bilayer structure of dimyristoylphosphatidylcholine (DMPC), to form a non-lamellar phase (most likely micellar). The ganglioside GM1 potentiated the effect of Aβ (1-40), as viewed from 31 P NMR. The difference of the isotropic peak intensity between DMPC/Aβ and DMPC/GM1/Aβ suggests a specific interaction between Aβ and GM1. We show that in the DMPC/GM1/Aβ system there are three lipid phases, namely a lamellar phase, a hexagonal phase and non-oriented lipids. The latter two phases are induced by the presence of the Aβ peptide, and facilitated by GM1.Key Words: β-amyloid, Alzheimer's disease, NMR, GM1-ganglioside, lipid bilayer Abbreviations: DMPC: dimyristoylphosphatidylcholine, Aβ: Amyloid β-peptide, AD:Alzheimer's disease, NMR: Nuclear Magnetic Resonance 3
IntroductionAlzheimer's disease (AD) is a devastating neurodegenerative disease affecting up to 15 million individuals worldwide. The brains of Alzheimer's disease patients are characterized by fibrillar amyloid plaques that are associated with progressive deposits (Iversen et al., 1995). The principal component of amyloid deposits is a 39-42 amino acid residue peptide, Aβ (Glenner et al., 1984;Masters et al., 1985), a product of proteolytic processing of a much larger amyloid precursor protein encoded by a gene on chromosome 21 (Kang et al., 1987). Several spectroscopic investigations have clarified the structure of the fibrils, which form a 'cross-β sheet' structure (Kirschner et al., 1986;Petkova et al., 2002;Petkova et al., 2006). Moreover, a link between Aβ and AD neuropathological lesions is demonstrated by the toxicity of aggregated Aβ to neuronal cells in culture (Lambert et al., 1998) and in aged brain (Geula et al., 1998). However, the molecular mechanisms of the neurotoxic action of Aβ remain unknown. A growing number of observations indicate that Aβ may alter the physicochemical properties of neuronal membranes, including membrane fluidity (Muller et al., 1995) and permeability to ions and nonelectrolytes (Arispe et al., 1993;de Planque et al., 2007; Lau et al., 2006).These findings strongly suggest that at least some of the pathophysiological effects of Aβ may be mediated by Aβ-membrane interactions. Indeed, a number of studies have shown that Aβ is able to perturb lipid bilayers (Arispe et al., 1993). Interest in studies of the interaction between Aβ and constituents of brain membranes has been further stimulated by the identification of an Aβ-GM1 ganglioside-bound form in AD brain (Chi et al., 2007; Kakio et al., 2002;Yanagisawa et al., 1995).
4Gangliosides (Brocca et al., 1997; Kasahara et al., 2001) are sialic acid-containing glycosphingolipids and consist of two main components: a hydrophobic...